Ticker League

FCF Margin for Vertex Pharmaceuticals (VRTX)

As of · Reported

Metric

TTM

30.3%

YoY change

+33.62pp

Trough year (2010)

-469.8%

Peak year (2020)

48.2%

FCF Margin history chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2025

Latest: 26.5%

FCF Margin change chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2025

Latest: +33.62pp

FCF Margin history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2025

  • 202526.5%+33.62pp
  • 2024-7.2%-40.40pp
  • 202333.2%-10.73pp
  • 202244.0%+12.15pp
  • 202131.8%-16.44pp
  • 202048.2%+12.36pp
  • 201935.9%-2.66pp
  • 201838.5%+15.02pp
  • 201723.5%+12.98pp
  • 201610.5%+50.33pp
  • 2015-39.8%+57.45pp
  • 2014-97.2%-88.75pp
  • 2013-8.5%-21.38pp
  • 201212.9%+9.40pp
  • 20113.5%+473.24pp
  • 2010-469.8%-27.74pp
  • 2009-442.0%-294.64pp
  • 2008-147.4%-4.23pp
  • 2007-143.2%-117.78pp
  • 2006-25.4%+92.11pp
  • 2005-117.5%+33.08pp
  • 2004-150.6%+116.97pp
  • 2003-267.5%-192.57pp
  • 2002-75.0%-37.96pp
  • 2001-37.0%-0.45pp
  • 2000-36.6%+41.37pp
  • 1999-77.9%+9.92pp
  • 1998-87.8%-52.68pp
  • 1997-35.2%+297.92pp
  • 1996-333.1%-236.25pp
  • 1995-96.8%-12.14pp
  • 1994-84.7%-109.07pp
  • 199324.4%+203.32pp
  • 1992-178.9%-63.32pp
  • 1991-115.6%—

FCF Margin values are taken from Vertex Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About FCF Margin at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported free cash flow margin is 30.3%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Vertex Pharmaceuticals (VRTX) free cash flow margin is 26.45% – expanded 33.6 percentage points year-over-year.

The highest annual free cash flow margin of 48.24% was reported in 2020. The lowest in the available history was -469.76% in 2010.

Vertex Pharmaceuticals FCF Margin by Year

Vertex Pharmaceuticals FCF Margin 2025: 26.5%

2025's free cash flow margin for Vertex Pharmaceuticals came in at 26.45%, expanded 33.6 percentage points from 2024.

Vertex Pharmaceuticals FCF Margin 2024: -7.2%

Vertex Pharmaceuticals posted free cash flow margin of -7.17% in 2024, contracted 40.4 percentage points from 2023.

Vertex Pharmaceuticals FCF Margin 2023: 33.2%

In 2023, Vertex Pharmaceuticals reported free cash flow margin of 33.22%, contracted 10.7 percentage points from 2022.

Vertex Pharmaceuticals FCF Margin 2022: 44.0%

Vertex Pharmaceuticals free cash flow margin in 2022 was 43.95%, expanded 12.2 percentage points from 2021.

Vertex Pharmaceuticals FCF Margin 2021: 31.8%

Vertex Pharmaceuticals free cash flow margin in 2021 was 31.80%.

See more financial history for Vertex Pharmaceuticals (VRTX).

Sector peers by FCF Margin

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest free cash flow margin

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends paid by this company.